节点文献

重视血液透析患者肺动脉高压的诊治

Concern for the diagnosis and treatment of pulmonary arterial hypertension in hemdialysis patients

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 韦洮于媛赵青艺

【Author】 WEI Tao;YU Yuan;ZHAO Qing-yi;Renal Department,Peking University People’s Hospital;

【机构】 北京大学人民医院肾内科

【摘要】 肺动脉高压(pulmonary arterial hypertension PAH)是一种引起右心衰竭,如果不治疗最终导致死亡的慢性进行性疾病,是血液透析患者常见的并发症,尤其是建立动静脉内瘘的透析患者,随着慢性肾脏病(chronic kidney disease,CKD)的进展,严重PAH的患病率和心血管死亡率呈明显上升趋势。其发病机制复杂,许多因素可以造成血液透析患者的肺动脉高压。临床上应早期识别肺动脉高压并给予积极的干预,减缓易患因素防止PAH发生发展。

【Abstract】 Pulmonary arterial hypertension(PAH) is a chronic and progressive disease leading to right heart failure and death if untreated.It is a common abnormality in patients with dialysis-dependent chronic kidney disease,especially those having arteriovenous fistula.With the increase of chronic kidney disease patients,the prevalence of severe PAH and the mortality of cardiac diseases are significantly increasing.Several factors cause the development and progression of PAH.Clinically,PAH should be identified and treated earlier to mitigate the susceptible factors and to prevent the development of PAH.

  • 【文献出处】 中国血液净化 ,Chinese Journal of Blood Purification , 编辑部邮箱 ,2017年05期
  • 【分类号】R544.1;R692.5
  • 【被引频次】7
  • 【下载频次】134
节点文献中: 

本文链接的文献网络图示:

本文的引文网络